Platysmaplasty Treatment Global Market Report 2024

The platysmaplasty treatment market size has grown strongly in recent years. It will grow from $1 billion in 2023 to $1.08 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. During the historical period, growth can be credited to demographic shifts towards an aging population, heightened awareness of cosmetic procedures, advancements in surgical techniques, rising disposable incomes, and the pervasive influence of celebrity culture.

The platysmaplasty treatment market size is expected to see strong growth in the next few years. It will grow to $1.47 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. In the forecast period, growth is expected to stem from the increasing demand for minimally invasive procedures, advancements in non-surgical options, the rise of medical tourism, regulatory modifications impacting safety standards, and evolving societal perceptions regarding aging and aesthetics. Major trends anticipated in this period include the rising preference for minimally invasive treatments, the integration of advanced technologies such as robotic-assisted surgery, a shift towards outpatient procedures, the expanding demographic of aging populations, and the formulation of personalized treatment strategies tailored to individual patient requirements.

The surge in demand for cosmetic procedures is anticipated to drive growth in the platysmaplasty treatment market. Cosmetic procedures encompass a variety of surgical and non-surgical interventions aimed at enhancing or altering an individual's physical appearance for aesthetic reasons. This escalating demand is fueled by societal emphasis on appearance, advancements in medical technology, and increasing acceptance of aesthetic enhancements to bolster self-esteem and overall well-being. Platysmaplasty treatment, utilized in cosmetic procedures, targets sagging or aging skin in the neck area, offering patients a rejuvenated and youthful look. For example, in September 2023, the International Society of Aesthetic Plastic Surgery (ISAPS) reported an 11.2% overall increase in procedures performed by plastic surgeons globally, with over 14.9 million surgical and 18.8 million non-surgical interventions, surpassing the 12.8 million surgical and 17.5 million non-surgical procedures conducted in 2021. Hence, the escalating demand for cosmetic procedures is poised to propel the platysmaplasty treatment market forward.

Key players in the platysmaplasty treatment market are directing their efforts towards aesthetic non-surgical procedures, such as non-invasive ultrasound parallel beams, to meet the growing demand for less invasive alternatives while delivering effective platysmaplasty treatment. Non-invasive ultrasound parallel beam technology offers precise and efficient treatment for platysmaplasty, addressing patient preferences for minimally invasive options with favorable outcomes. For instance, in November 2021, Sofwave Medical Ltd., an Israel-based company specializing in aesthetic medicine, announced FDA approval for expanded indications, including eyebrow lifting and treatment of lax submental and neck tissues in individuals aged 22 and older. Moreover, the Sofwave system, powered by SUPERB technology, received FDA clearance for non-invasive dermatological aesthetic treatment to improve facial lines and wrinkles. The synchronized ultrasound parallel beam technology emerged as a leading solution in the industry, offering practitioners non-invasive alternatives for desired lifting treatments of the face and neck.

In June 2022, Sono Bello, a US-based provider of personalized cosmetic procedures for body contouring and facial rejuvenation, completed the acquisition of Body Sculpt International for an undisclosed sum. This acquisition strengthens Sono Bello's position as the foremost national brand for safe and effective liposuction surgery and body contouring procedures. Body Sculpt International specializes in neck lift surgeries and body contouring procedures, further enhancing Sono Bello's portfolio.

Major companies operating in the platysmaplasty treatment market are Mayo Clinic, Cleveland Clinic Foundation, Duke Health, Lumenis Ltd., Cutera Inc., Lutronic Corporation, Sinclair Pharma plc, Candela Corporation, Merz Aesthetics, Piedmont Plastic Surgery & Dermatology, Quanta System S.p.A., Long Island Plastic Surgical Group, Westlake Dermatology & Cosmetic Surgery, Allergan Aesthetics, The Esthetic Clinics, Cadogan Clinic, BTL Aesthetics Inc., Avenue Plastic Surgery, Dr. Cat Plastic Surgery, Los Angeles Plastic Surgery Clinic, Nazarian Plastic Surgery, The Istanbul Aesthetic Center, Cypris Medical, Marina Plastic Surgery, Elite Plastic Surgery.

North America was the largest region in the platysmaplasty treatment market in 2023. The regions covered in the platysmaplasty treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the platysmaplasty treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Platysmaplasty treatment entails a surgical procedure designed to enhance the aesthetics of the neck by tightening muscles and reducing surplus skin. It specifically addresses the platysma muscle, which can slacken over time due to aging or weight loss, resulting in the formation of neck bands or a turkey-wattle appearance.

The primary categories of procedures in platysmaplasty treatments include surgical and non-surgical methods. Surgical platysmaplasty employs invasive techniques, involving incisions in the neck region to directly access and tighten the platysma muscle. These treatments cater to both genders, male and female, and are commonly conducted in cosmetic surgery clinics and hospitals.

The platysmaplasty treatment market research report is one of a series of new reports that provides platysmaplasty treatment market statistics, including platysmaplasty treatment industry global market size, regional shares, competitors with a platysmaplasty treatment market share, detailed platysmaplasty treatment market segments, market trends and opportunities, and any further data you may need to thrive in the platysmaplasty treatment industry. This platysmaplasty treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The platysmaplasty treatment market consists of revenues earned by entities by providing services such as consultation and assessment, postoperative care, skincare, and maintenance. The market value includes the value of related goods sold by the service provider or included within the service offering. The platysmaplasty treatment market also includes sales of surgical instruments, equipment, implants, materials, topical treatments, and compression garments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.